Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals

Lipid-Lowering Agents - APAC

APAC
  • Revenue in the Lipid-Lowering Agents market is projected to reach US$1.57bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 0.43%, resulting in a market volume of US$1.60bn by 2028.
  • In global comparison, most revenue will be generated United States (US$4.46bn in 2024).

Definition:
The Lipid-Lowering Agents market covers drugs to treat hyperlipidemia or dyslipidemia. These metabolic disorders are characterized by high levels of lipids, such as fats, cholesterol, or triglycerides, or lipoproteins in the blood. Different drug classes are included: statins, PCSK9 inhibitors, bile acid sequestrants, cholesterol absorption inhibitors, fibric acid derivatives, as well as combinations thereof.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Merck & Co., AstraZeneca, Viatris

In-Scope

  • Anti-hyperlipidemics
  • Drugs to treat high levels of lipids in the blood
  • Cholesterol-lowering drugs

Out-Of-Scope

  • Anti-diabetes drugs
  • Drugs to treat other metabolic disorders
  • Dietary supplements
Pharmaceuticals

Pharmaceuticals

Related markets:
Lipid-Lowering Agents: market data & analysis - Cover

Market Insights report

Lipid-Lowering Agents: market data & analysis

Study Details
    methodology

    Download PDF

    FAQs and more info on the methodology

    Revenue

    Notes: Data was converted from local currencies using average exchange rates of the respective year.

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Analyst Opinion

    As therapies with lipid-lowering agents are usually of a long-term nature, the growth of this market is rather driven by the prices of these products than by the number of patients. Nevertheless, limited access to healthcare facilities owing to the COVID-19 pandemic has had some negative impact, which is reflected in lower growth rates in 2020. While generics have a considerable share, expiring patents as well as new products strongly influence the dynamics of the market.

    Global Comparison

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Lipid-Lowering Agents: market data & analysis - BackgroundLipid-Lowering Agents: market data & analysis - Cover

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.
    More data on the topic
    Revenue of the worldwide pharmaceutical market in 2023
    1.6tr USD
    Revenue share of the North American pharmaceutical market in 2023
    53.3%
    Pharmaceutical sales in oncologics in 2023
    214bn USD

    Contact

    Get in touch with us. We are happy to help.